nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—CHRM3—ureter—prostate cancer	0.0548	0.234	CbGeAlD
Succinylcholine—CHRNG—prostate gland—prostate cancer	0.024	0.102	CbGeAlD
Succinylcholine—CHRNE—testis—prostate cancer	0.0211	0.0901	CbGeAlD
Succinylcholine—CHRNG—seminal vesicle—prostate cancer	0.0203	0.0864	CbGeAlD
Succinylcholine—CHRNA1—prostate gland—prostate cancer	0.0159	0.0676	CbGeAlD
Succinylcholine—CHRNG—bone marrow—prostate cancer	0.0124	0.0527	CbGeAlD
Succinylcholine—CHRNB1—prostate gland—prostate cancer	0.0123	0.0522	CbGeAlD
Succinylcholine—CHRNA10—testis—prostate cancer	0.00895	0.0382	CbGeAlD
Succinylcholine—Decamethonium—ACHE—prostate cancer	0.00859	1	CrCbGaD
Succinylcholine—CHRM2—prostate gland—prostate cancer	0.00785	0.0335	CbGeAlD
Succinylcholine—CHRM1—prostate gland—prostate cancer	0.00715	0.0305	CbGeAlD
Succinylcholine—CHRNA10—lymph node—prostate cancer	0.00649	0.0277	CbGeAlD
Succinylcholine—CHRM3—prostate gland—prostate cancer	0.0064	0.0273	CbGeAlD
Succinylcholine—Cardiac arrest—Estramustine—prostate cancer	0.00612	0.0125	CcSEcCtD
Succinylcholine—Trismus—Capecitabine—prostate cancer	0.00585	0.012	CcSEcCtD
Succinylcholine—CHRNB1—testis—prostate cancer	0.0054	0.023	CbGeAlD
Succinylcholine—BCHE—prostate gland—prostate cancer	0.00522	0.0223	CbGeAlD
Succinylcholine—Renal failure acute—Cabazitaxel—prostate cancer	0.00521	0.0107	CcSEcCtD
Succinylcholine—Hypertonia—Bicalutamide—prostate cancer	0.00498	0.0102	CcSEcCtD
Succinylcholine—Cardiac arrest—Cabazitaxel—prostate cancer	0.00457	0.00937	CcSEcCtD
Succinylcholine—BCHE—seminal vesicle—prostate cancer	0.00442	0.0188	CbGeAlD
Succinylcholine—CHRM3—renal system—prostate cancer	0.00436	0.0186	CbGeAlD
Succinylcholine—CHRM3—urethra—prostate cancer	0.00428	0.0183	CbGeAlD
Succinylcholine—Flushing—Estramustine—prostate cancer	0.00413	0.00847	CcSEcCtD
Succinylcholine—Intraocular pressure increased—Prednisone—prostate cancer	0.00396	0.00811	CcSEcCtD
Succinylcholine—Cardiac arrest—Bicalutamide—prostate cancer	0.00392	0.00804	CcSEcCtD
Succinylcholine—CHRNB1—lymph node—prostate cancer	0.00391	0.0167	CbGeAlD
Succinylcholine—Renal failure—Degarelix—prostate cancer	0.00387	0.00792	CcSEcCtD
Succinylcholine—Arrhythmia—Abiraterone—prostate cancer	0.00386	0.00792	CcSEcCtD
Succinylcholine—Renal failure—Cabazitaxel—prostate cancer	0.00364	0.00746	CcSEcCtD
Succinylcholine—Hypertonia—Goserelin—prostate cancer	0.00346	0.0071	CcSEcCtD
Succinylcholine—Hypertonia—Conjugated Estrogens—prostate cancer	0.00343	0.00703	CcSEcCtD
Succinylcholine—Hypertension—Abiraterone—prostate cancer	0.00325	0.00666	CcSEcCtD
Succinylcholine—Myalgia—Abiraterone—prostate cancer	0.00321	0.00657	CcSEcCtD
Succinylcholine—Arrhythmia—Degarelix—prostate cancer	0.00315	0.00646	CcSEcCtD
Succinylcholine—Flushing—Cabazitaxel—prostate cancer	0.00309	0.00632	CcSEcCtD
Succinylcholine—Renal failure acute—Conjugated Estrogens—prostate cancer	0.00308	0.00631	CcSEcCtD
Succinylcholine—Anaphylactic shock—Estrone—prostate cancer	0.00302	0.00619	CcSEcCtD
Succinylcholine—Arrhythmia—Cabazitaxel—prostate cancer	0.00297	0.00609	CcSEcCtD
Succinylcholine—Hypertension—Nilutamide—prostate cancer	0.00297	0.00609	CcSEcCtD
Succinylcholine—Hypertension—Flutamide—prostate cancer	0.00296	0.00606	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Conjugated Estrogens—prostate cancer	0.00294	0.00602	CcSEcCtD
Succinylcholine—Bradycardia—Bicalutamide—prostate cancer	0.0029	0.00595	CcSEcCtD
Succinylcholine—Hyperkalaemia—Mitoxantrone—prostate cancer	0.00287	0.00588	CcSEcCtD
Succinylcholine—Apnoea—Etoposide—prostate cancer	0.00286	0.00587	CcSEcCtD
Succinylcholine—CHRM3—testis—prostate cancer	0.00282	0.012	CbGeAlD
Succinylcholine—Musculoskeletal discomfort—Abiraterone—prostate cancer	0.0028	0.00574	CcSEcCtD
Succinylcholine—Shock—Nilutamide—prostate cancer	0.00276	0.00566	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Estrone—prostate cancer	0.00275	0.00564	CcSEcCtD
Succinylcholine—Hypertonia—Estradiol—prostate cancer	0.00275	0.00563	CcSEcCtD
Succinylcholine—BCHE—bone marrow—prostate cancer	0.00269	0.0115	CbGeAlD
Succinylcholine—Hypertension—Degarelix—prostate cancer	0.00265	0.00544	CcSEcCtD
Succinylcholine—Anaphylactic shock—Estradiol valerate/Dienogest—prostate cancer	0.00264	0.00541	CcSEcCtD
Succinylcholine—Ventricular fibrillation—Capecitabine—prostate cancer	0.00255	0.00523	CcSEcCtD
Succinylcholine—Arrhythmia—Bicalutamide—prostate cancer	0.00255	0.00522	CcSEcCtD
Succinylcholine—Anaphylactic shock—Degarelix—prostate cancer	0.00251	0.00514	CcSEcCtD
Succinylcholine—Hypertension—Cabazitaxel—prostate cancer	0.0025	0.00512	CcSEcCtD
Succinylcholine—Myalgia—Cabazitaxel—prostate cancer	0.00246	0.00505	CcSEcCtD
Succinylcholine—Body temperature increased—Abiraterone—prostate cancer	0.00243	0.00498	CcSEcCtD
Succinylcholine—Bronchospasm—Conjugated Estrogens—prostate cancer	0.00242	0.00495	CcSEcCtD
Succinylcholine—Urticaria—Estrone—prostate cancer	0.0024	0.00492	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Estradiol—prostate cancer	0.00235	0.00482	CcSEcCtD
Succinylcholine—Hypotension—Degarelix—prostate cancer	0.00234	0.0048	CcSEcCtD
Succinylcholine—Tachycardia—Cabazitaxel—prostate cancer	0.00231	0.00473	CcSEcCtD
Succinylcholine—BCHE—testis—prostate cancer	0.0023	0.0098	CbGeAlD
Succinylcholine—Renal failure acute—Mitoxantrone—prostate cancer	0.00229	0.0047	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Degarelix—prostate cancer	0.00228	0.00468	CcSEcCtD
Succinylcholine—Body temperature increased—Nilutamide—prostate cancer	0.00222	0.00455	CcSEcCtD
Succinylcholine—Hypotension—Cabazitaxel—prostate cancer	0.00221	0.00452	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Mitoxantrone—prostate cancer	0.00219	0.00449	CcSEcCtD
Succinylcholine—Renal failure—Goserelin—prostate cancer	0.00217	0.00445	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Cabazitaxel—prostate cancer	0.00215	0.00441	CcSEcCtD
Succinylcholine—Renal failure—Conjugated Estrogens—prostate cancer	0.00215	0.00441	CcSEcCtD
Succinylcholine—Hypertension—Bicalutamide—prostate cancer	0.00214	0.00439	CcSEcCtD
Succinylcholine—Myalgia—Bicalutamide—prostate cancer	0.00211	0.00433	CcSEcCtD
Succinylcholine—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.0021	0.00429	CcSEcCtD
Succinylcholine—Respiratory failure—Docetaxel—prostate cancer	0.00205	0.00421	CcSEcCtD
Succinylcholine—Rash—Estramustine—prostate cancer	0.00199	0.00409	CcSEcCtD
Succinylcholine—Shock—Bicalutamide—prostate cancer	0.00199	0.00409	CcSEcCtD
Succinylcholine—Dermatitis—Estramustine—prostate cancer	0.00199	0.00408	CcSEcCtD
Succinylcholine—Urticaria—Degarelix—prostate cancer	0.00199	0.00408	CcSEcCtD
Succinylcholine—Body temperature increased—Degarelix—prostate cancer	0.00198	0.00406	CcSEcCtD
Succinylcholine—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.00194	0.00398	CcSEcCtD
Succinylcholine—Rash—Abiraterone—prostate cancer	0.00194	0.00397	CcSEcCtD
Succinylcholine—Dermatitis—Abiraterone—prostate cancer	0.00194	0.00397	CcSEcCtD
Succinylcholine—Bronchospasm—Estradiol—prostate cancer	0.00193	0.00396	CcSEcCtD
Succinylcholine—Rash—Estrone—prostate cancer	0.00191	0.00391	CcSEcCtD
Succinylcholine—Dermatitis—Estrone—prostate cancer	0.0019	0.0039	CcSEcCtD
Succinylcholine—Body temperature increased—Cabazitaxel—prostate cancer	0.00187	0.00383	CcSEcCtD
Succinylcholine—Hypersensitivity—Degarelix—prostate cancer	0.00185	0.00379	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Bicalutamide—prostate cancer	0.00185	0.00378	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Etoposide—prostate cancer	0.00182	0.00373	CcSEcCtD
Succinylcholine—Pulmonary oedema—Docetaxel—prostate cancer	0.0018	0.00368	CcSEcCtD
Succinylcholine—Arrhythmia—Goserelin—prostate cancer	0.00177	0.00363	CcSEcCtD
Succinylcholine—Rash—Nilutamide—prostate cancer	0.00177	0.00363	CcSEcCtD
Succinylcholine—Dermatitis—Nilutamide—prostate cancer	0.00177	0.00362	CcSEcCtD
Succinylcholine—Rash—Flutamide—prostate cancer	0.00176	0.00361	CcSEcCtD
Succinylcholine—Dermatitis—Flutamide—prostate cancer	0.00176	0.00361	CcSEcCtD
Succinylcholine—Arrhythmia—Conjugated Estrogens—prostate cancer	0.00176	0.0036	CcSEcCtD
Succinylcholine—Hypersensitivity—Cabazitaxel—prostate cancer	0.00174	0.00357	CcSEcCtD
Succinylcholine—Cardiac arrest—Etoposide—prostate cancer	0.00168	0.00343	CcSEcCtD
Succinylcholine—BCHE—lymph node—prostate cancer	0.00167	0.00711	CbGeAlD
Succinylcholine—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00166	0.00341	CcSEcCtD
Succinylcholine—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00166	0.00341	CcSEcCtD
Succinylcholine—Urticaria—Bicalutamide—prostate cancer	0.00161	0.0033	CcSEcCtD
Succinylcholine—Renal failure—Mitoxantrone—prostate cancer	0.00161	0.00329	CcSEcCtD
Succinylcholine—Body temperature increased—Bicalutamide—prostate cancer	0.0016	0.00328	CcSEcCtD
Succinylcholine—Rash—Degarelix—prostate cancer	0.00158	0.00324	CcSEcCtD
Succinylcholine—Dermatitis—Degarelix—prostate cancer	0.00158	0.00324	CcSEcCtD
Succinylcholine—Pulmonary oedema—Prednisone—prostate cancer	0.00155	0.00317	CcSEcCtD
Succinylcholine—Renal failure acute—Capecitabine—prostate cancer	0.00154	0.00315	CcSEcCtD
Succinylcholine—Bronchospasm—Etoposide—prostate cancer	0.0015	0.00307	CcSEcCtD
Succinylcholine—Hypersensitivity—Bicalutamide—prostate cancer	0.00149	0.00306	CcSEcCtD
Succinylcholine—Bradycardia—Mitoxantrone—prostate cancer	0.00149	0.00306	CcSEcCtD
Succinylcholine—Hypertension—Goserelin—prostate cancer	0.00149	0.00306	CcSEcCtD
Succinylcholine—Myalgia—Goserelin—prostate cancer	0.00147	0.00301	CcSEcCtD
Succinylcholine—Flushing—Estradiol—prostate cancer	0.00146	0.00299	CcSEcCtD
Succinylcholine—Myalgia—Conjugated Estrogens—prostate cancer	0.00146	0.00299	CcSEcCtD
Succinylcholine—Anaphylactic shock—Goserelin—prostate cancer	0.00141	0.00289	CcSEcCtD
Succinylcholine—Anaphylactic shock—Conjugated Estrogens—prostate cancer	0.0014	0.00286	CcSEcCtD
Succinylcholine—Shock—Goserelin—prostate cancer	0.00139	0.00284	CcSEcCtD
Succinylcholine—Tachycardia—Goserelin—prostate cancer	0.00138	0.00282	CcSEcCtD
Succinylcholine—Shock—Conjugated Estrogens—prostate cancer	0.00137	0.00282	CcSEcCtD
Succinylcholine—Tachycardia—Conjugated Estrogens—prostate cancer	0.00136	0.00279	CcSEcCtD
Succinylcholine—Urticaria—Ethinyl Estradiol—prostate cancer	0.00136	0.00279	CcSEcCtD
Succinylcholine—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.00135	0.00278	CcSEcCtD
Succinylcholine—Cardiac arrest—Capecitabine—prostate cancer	0.00135	0.00276	CcSEcCtD
Succinylcholine—Hyperkalaemia—Epirubicin—prostate cancer	0.00134	0.00274	CcSEcCtD
Succinylcholine—Renal failure—Etoposide—prostate cancer	0.00134	0.00274	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Epirubicin—prostate cancer	0.00132	0.00271	CcSEcCtD
Succinylcholine—Hypotension—Goserelin—prostate cancer	0.00132	0.0027	CcSEcCtD
Succinylcholine—Arrhythmia—Mitoxantrone—prostate cancer	0.00131	0.00268	CcSEcCtD
Succinylcholine—Hypotension—Conjugated Estrogens—prostate cancer	0.0013	0.00267	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Goserelin—prostate cancer	0.00128	0.00263	CcSEcCtD
Succinylcholine—Rash—Bicalutamide—prostate cancer	0.00128	0.00262	CcSEcCtD
Succinylcholine—Dermatitis—Bicalutamide—prostate cancer	0.00128	0.00262	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Conjugated Estrogens—prostate cancer	0.00127	0.00261	CcSEcCtD
Succinylcholine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00126	0.00259	CcSEcCtD
Succinylcholine—Bronchospasm—Docetaxel—prostate cancer	0.00125	0.00255	CcSEcCtD
Succinylcholine—Hyperkalaemia—Doxorubicin—prostate cancer	0.00124	0.00254	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Doxorubicin—prostate cancer	0.00122	0.00251	CcSEcCtD
Succinylcholine—Pulmonary oedema—Epirubicin—prostate cancer	0.00121	0.00248	CcSEcCtD
Succinylcholine—Bronchospasm—Capecitabine—prostate cancer	0.00121	0.00247	CcSEcCtD
Succinylcholine—Cardiac arrest—Prednisone—prostate cancer	0.0012	0.00246	CcSEcCtD
Succinylcholine—Hypertonia—Epirubicin—prostate cancer	0.00119	0.00244	CcSEcCtD
Succinylcholine—Hypertension—Estradiol—prostate cancer	0.00118	0.00242	CcSEcCtD
Succinylcholine—Myalgia—Estradiol—prostate cancer	0.00117	0.00239	CcSEcCtD
Succinylcholine—Flushing—Etoposide—prostate cancer	0.00113	0.00232	CcSEcCtD
Succinylcholine—Pulmonary oedema—Doxorubicin—prostate cancer	0.00112	0.0023	CcSEcCtD
Succinylcholine—Urticaria—Goserelin—prostate cancer	0.00112	0.0023	CcSEcCtD
Succinylcholine—Anaphylactic shock—Estradiol—prostate cancer	0.00112	0.00229	CcSEcCtD
Succinylcholine—Body temperature increased—Goserelin—prostate cancer	0.00111	0.00228	CcSEcCtD
Succinylcholine—Renal failure—Docetaxel—prostate cancer	0.00111	0.00227	CcSEcCtD
Succinylcholine—Urticaria—Conjugated Estrogens—prostate cancer	0.00111	0.00227	CcSEcCtD
Succinylcholine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.0011	0.00226	CcSEcCtD
Succinylcholine—Hypertonia—Doxorubicin—prostate cancer	0.0011	0.00226	CcSEcCtD
Succinylcholine—Hypertension—Mitoxantrone—prostate cancer	0.0011	0.00226	CcSEcCtD
Succinylcholine—Shock—Estradiol—prostate cancer	0.0011	0.00225	CcSEcCtD
Succinylcholine—Tachycardia—Estradiol—prostate cancer	0.00109	0.00224	CcSEcCtD
Succinylcholine—Myalgia—Mitoxantrone—prostate cancer	0.00109	0.00223	CcSEcCtD
Succinylcholine—Rash—Ethinyl Estradiol—prostate cancer	0.00108	0.00221	CcSEcCtD
Succinylcholine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00108	0.00221	CcSEcCtD
Succinylcholine—Renal failure—Capecitabine—prostate cancer	0.00107	0.0022	CcSEcCtD
Succinylcholine—Renal failure acute—Epirubicin—prostate cancer	0.00107	0.00219	CcSEcCtD
Succinylcholine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00104	0.00213	CcSEcCtD
Succinylcholine—Hypersensitivity—Goserelin—prostate cancer	0.00104	0.00213	CcSEcCtD
Succinylcholine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.00103	0.00211	CcSEcCtD
Succinylcholine—Shock—Mitoxantrone—prostate cancer	0.00102	0.0021	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Epirubicin—prostate cancer	0.00102	0.00209	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Estradiol—prostate cancer	0.00102	0.00209	CcSEcCtD
Succinylcholine—Tachycardia—Mitoxantrone—prostate cancer	0.00102	0.00208	CcSEcCtD
Succinylcholine—Bradycardia—Capecitabine—prostate cancer	0.000999	0.00205	CcSEcCtD
Succinylcholine—Renal failure acute—Doxorubicin—prostate cancer	0.00099	0.00203	CcSEcCtD
Succinylcholine—Hypotension—Mitoxantrone—prostate cancer	0.000973	0.00199	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000949	0.00194	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000944	0.00194	CcSEcCtD
Succinylcholine—Flushing—Docetaxel—prostate cancer	0.00094	0.00193	CcSEcCtD
Succinylcholine—Cardiac arrest—Epirubicin—prostate cancer	0.000939	0.00193	CcSEcCtD
Succinylcholine—Hypertension—Etoposide—prostate cancer	0.000916	0.00188	CcSEcCtD
Succinylcholine—Flushing—Capecitabine—prostate cancer	0.00091	0.00187	CcSEcCtD
Succinylcholine—Arrhythmia—Docetaxel—prostate cancer	0.000905	0.00186	CcSEcCtD
Succinylcholine—Bradycardia—Prednisone—prostate cancer	0.00089	0.00182	CcSEcCtD
Succinylcholine—Rash—Goserelin—prostate cancer	0.000889	0.00182	CcSEcCtD
Succinylcholine—Dermatitis—Goserelin—prostate cancer	0.000888	0.00182	CcSEcCtD
Succinylcholine—Urticaria—Estradiol—prostate cancer	0.000888	0.00182	CcSEcCtD
Succinylcholine—Body temperature increased—Estradiol—prostate cancer	0.000884	0.00181	CcSEcCtD
Succinylcholine—Rash—Conjugated Estrogens—prostate cancer	0.00088	0.0018	CcSEcCtD
Succinylcholine—Dermatitis—Conjugated Estrogens—prostate cancer	0.00088	0.0018	CcSEcCtD
Succinylcholine—Arrhythmia—Capecitabine—prostate cancer	0.000876	0.0018	CcSEcCtD
Succinylcholine—Cardiac arrest—Doxorubicin—prostate cancer	0.000869	0.00178	CcSEcCtD
Succinylcholine—Anaphylactic shock—Etoposide—prostate cancer	0.000866	0.00178	CcSEcCtD
Succinylcholine—Tachycardia—Etoposide—prostate cancer	0.000845	0.00173	CcSEcCtD
Succinylcholine—Urticaria—Mitoxantrone—prostate cancer	0.000827	0.0017	CcSEcCtD
Succinylcholine—Hypersensitivity—Estradiol—prostate cancer	0.000823	0.00169	CcSEcCtD
Succinylcholine—Body temperature increased—Mitoxantrone—prostate cancer	0.000823	0.00169	CcSEcCtD
Succinylcholine—Flushing—Prednisone—prostate cancer	0.000811	0.00166	CcSEcCtD
Succinylcholine—Hypotension—Etoposide—prostate cancer	0.000809	0.00166	CcSEcCtD
Succinylcholine—Arrhythmia—Prednisone—prostate cancer	0.000781	0.0016	CcSEcCtD
Succinylcholine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000767	0.00157	CcSEcCtD
Succinylcholine—Hypertension—Docetaxel—prostate cancer	0.000762	0.00156	CcSEcCtD
Succinylcholine—Myalgia—Docetaxel—prostate cancer	0.000751	0.00154	CcSEcCtD
Succinylcholine—Renal failure—Epirubicin—prostate cancer	0.000748	0.00153	CcSEcCtD
Succinylcholine—Hypertension—Capecitabine—prostate cancer	0.000737	0.00151	CcSEcCtD
Succinylcholine—Myalgia—Capecitabine—prostate cancer	0.000727	0.00149	CcSEcCtD
Succinylcholine—Anaphylactic shock—Docetaxel—prostate cancer	0.00072	0.00148	CcSEcCtD
Succinylcholine—Shock—Docetaxel—prostate cancer	0.000708	0.00145	CcSEcCtD
Succinylcholine—Rash—Estradiol—prostate cancer	0.000705	0.00144	CcSEcCtD
Succinylcholine—Dermatitis—Estradiol—prostate cancer	0.000704	0.00144	CcSEcCtD
Succinylcholine—Tachycardia—Docetaxel—prostate cancer	0.000703	0.00144	CcSEcCtD
Succinylcholine—Bradycardia—Epirubicin—prostate cancer	0.000696	0.00143	CcSEcCtD
Succinylcholine—Renal failure—Doxorubicin—prostate cancer	0.000692	0.00142	CcSEcCtD
Succinylcholine—Urticaria—Etoposide—prostate cancer	0.000688	0.00141	CcSEcCtD
Succinylcholine—Shock—Capecitabine—prostate cancer	0.000686	0.00141	CcSEcCtD
Succinylcholine—Body temperature increased—Etoposide—prostate cancer	0.000685	0.0014	CcSEcCtD
Succinylcholine—Tachycardia—Capecitabine—prostate cancer	0.00068	0.00139	CcSEcCtD
Succinylcholine—Hypotension—Docetaxel—prostate cancer	0.000673	0.00138	CcSEcCtD
Succinylcholine—Hypertension—Prednisone—prostate cancer	0.000657	0.00135	CcSEcCtD
Succinylcholine—Rash—Mitoxantrone—prostate cancer	0.000657	0.00135	CcSEcCtD
Succinylcholine—Dermatitis—Mitoxantrone—prostate cancer	0.000656	0.00134	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000656	0.00134	CcSEcCtD
Succinylcholine—Hypotension—Capecitabine—prostate cancer	0.000651	0.00133	CcSEcCtD
Succinylcholine—Myalgia—Prednisone—prostate cancer	0.000648	0.00133	CcSEcCtD
Succinylcholine—Bradycardia—Doxorubicin—prostate cancer	0.000644	0.00132	CcSEcCtD
Succinylcholine—Hypersensitivity—Etoposide—prostate cancer	0.000638	0.00131	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000635	0.0013	CcSEcCtD
Succinylcholine—Flushing—Epirubicin—prostate cancer	0.000634	0.0013	CcSEcCtD
Succinylcholine—Anaphylactic shock—Prednisone—prostate cancer	0.000621	0.00127	CcSEcCtD
Succinylcholine—Shock—Prednisone—prostate cancer	0.000611	0.00125	CcSEcCtD
Succinylcholine—Arrhythmia—Epirubicin—prostate cancer	0.000611	0.00125	CcSEcCtD
Succinylcholine—Tachycardia—Prednisone—prostate cancer	0.000606	0.00124	CcSEcCtD
Succinylcholine—Flushing—Doxorubicin—prostate cancer	0.000587	0.0012	CcSEcCtD
Succinylcholine—Body temperature increased—Docetaxel—prostate cancer	0.000569	0.00117	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000566	0.00116	CcSEcCtD
Succinylcholine—Arrhythmia—Doxorubicin—prostate cancer	0.000565	0.00116	CcSEcCtD
Succinylcholine—Urticaria—Capecitabine—prostate cancer	0.000554	0.00113	CcSEcCtD
Succinylcholine—Body temperature increased—Capecitabine—prostate cancer	0.000551	0.00113	CcSEcCtD
Succinylcholine—Rash—Etoposide—prostate cancer	0.000546	0.00112	CcSEcCtD
Succinylcholine—Dermatitis—Etoposide—prostate cancer	0.000546	0.00112	CcSEcCtD
Succinylcholine—Hypersensitivity—Docetaxel—prostate cancer	0.00053	0.00109	CcSEcCtD
Succinylcholine—Hypertension—Epirubicin—prostate cancer	0.000514	0.00105	CcSEcCtD
Succinylcholine—Hypersensitivity—Capecitabine—prostate cancer	0.000513	0.00105	CcSEcCtD
Succinylcholine—Myalgia—Epirubicin—prostate cancer	0.000507	0.00104	CcSEcCtD
Succinylcholine—Urticaria—Prednisone—prostate cancer	0.000493	0.00101	CcSEcCtD
Succinylcholine—Body temperature increased—Prednisone—prostate cancer	0.000491	0.00101	CcSEcCtD
Succinylcholine—Anaphylactic shock—Epirubicin—prostate cancer	0.000486	0.000995	CcSEcCtD
Succinylcholine—Shock—Epirubicin—prostate cancer	0.000478	0.000979	CcSEcCtD
Succinylcholine—Hypertension—Doxorubicin—prostate cancer	0.000475	0.000974	CcSEcCtD
Succinylcholine—Tachycardia—Epirubicin—prostate cancer	0.000474	0.000971	CcSEcCtD
Succinylcholine—Myalgia—Doxorubicin—prostate cancer	0.000469	0.00096	CcSEcCtD
Succinylcholine—Hypersensitivity—Prednisone—prostate cancer	0.000457	0.000937	CcSEcCtD
Succinylcholine—Rash—Docetaxel—prostate cancer	0.000454	0.00093	CcSEcCtD
Succinylcholine—Hypotension—Epirubicin—prostate cancer	0.000454	0.00093	CcSEcCtD
Succinylcholine—Dermatitis—Docetaxel—prostate cancer	0.000453	0.000929	CcSEcCtD
Succinylcholine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000449	0.000921	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000442	0.000907	CcSEcCtD
Succinylcholine—Shock—Doxorubicin—prostate cancer	0.000442	0.000906	CcSEcCtD
Succinylcholine—Rash—Capecitabine—prostate cancer	0.000439	0.000901	CcSEcCtD
Succinylcholine—Dermatitis—Capecitabine—prostate cancer	0.000439	0.0009	CcSEcCtD
Succinylcholine—Tachycardia—Doxorubicin—prostate cancer	0.000438	0.000899	CcSEcCtD
Succinylcholine—Hypotension—Doxorubicin—prostate cancer	0.00042	0.00086	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000409	0.000839	CcSEcCtD
Succinylcholine—Rash—Prednisone—prostate cancer	0.000391	0.000802	CcSEcCtD
Succinylcholine—Dermatitis—Prednisone—prostate cancer	0.000391	0.000802	CcSEcCtD
Succinylcholine—Urticaria—Epirubicin—prostate cancer	0.000386	0.000791	CcSEcCtD
Succinylcholine—Body temperature increased—Epirubicin—prostate cancer	0.000384	0.000787	CcSEcCtD
Succinylcholine—Hypersensitivity—Epirubicin—prostate cancer	0.000358	0.000733	CcSEcCtD
Succinylcholine—Urticaria—Doxorubicin—prostate cancer	0.000357	0.000731	CcSEcCtD
Succinylcholine—Body temperature increased—Doxorubicin—prostate cancer	0.000355	0.000728	CcSEcCtD
Succinylcholine—Hypersensitivity—Doxorubicin—prostate cancer	0.000331	0.000678	CcSEcCtD
Succinylcholine—Rash—Epirubicin—prostate cancer	0.000306	0.000627	CcSEcCtD
Succinylcholine—Dermatitis—Epirubicin—prostate cancer	0.000306	0.000627	CcSEcCtD
Succinylcholine—Rash—Doxorubicin—prostate cancer	0.000283	0.000581	CcSEcCtD
Succinylcholine—Dermatitis—Doxorubicin—prostate cancer	0.000283	0.00058	CcSEcCtD
Succinylcholine—CHRM2—Signaling Pathways—NGFR—prostate cancer	2.8e-05	0.000104	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAP3K7—prostate cancer	2.8e-05	0.000104	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAP3K7—prostate cancer	2.77e-05	0.000103	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—LPL—prostate cancer	2.76e-05	0.000103	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CG—prostate cancer	2.72e-05	0.000101	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FGF10—prostate cancer	2.7e-05	0.0001	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FGF10—prostate cancer	2.69e-05	0.0001	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ADRB2—prostate cancer	2.67e-05	9.93e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CYP1A1—prostate cancer	2.67e-05	9.92e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FGF10—prostate cancer	2.66e-05	9.91e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ADRB2—prostate cancer	2.66e-05	9.9e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ERCC2—prostate cancer	2.64e-05	9.83e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ADRB2—prostate cancer	2.64e-05	9.8e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—JAK2—prostate cancer	2.63e-05	9.8e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—JAK2—prostate cancer	2.63e-05	9.77e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—MAP2K1—prostate cancer	2.62e-05	9.76e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—MAP2K1—prostate cancer	2.62e-05	9.73e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CD—prostate cancer	2.61e-05	9.69e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VAV3—prostate cancer	2.6e-05	9.69e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—JAK2—prostate cancer	2.6e-05	9.67e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CD—prostate cancer	2.6e-05	9.66e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VAV3—prostate cancer	2.6e-05	9.65e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—MAP2K1—prostate cancer	2.59e-05	9.63e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CD—prostate cancer	2.57e-05	9.57e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VAV3—prostate cancer	2.57e-05	9.56e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—INS—prostate cancer	2.57e-05	9.56e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TGFBR2—prostate cancer	2.57e-05	9.55e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TGFBR2—prostate cancer	2.56e-05	9.52e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TGFBR2—prostate cancer	2.53e-05	9.42e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ITPR1—prostate cancer	2.53e-05	9.39e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ITPR1—prostate cancer	2.52e-05	9.36e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CREBBP—prostate cancer	2.52e-05	9.36e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CB—prostate cancer	2.5e-05	9.31e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CB—prostate cancer	2.49e-05	9.28e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ITPR1—prostate cancer	2.49e-05	9.27e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—MTHFR—prostate cancer	2.49e-05	9.24e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CB—prostate cancer	2.47e-05	9.19e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PPARA—prostate cancer	2.44e-05	9.07e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF1R—prostate cancer	2.42e-05	8.98e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF1R—prostate cancer	2.41e-05	8.95e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CXCL8—prostate cancer	2.4e-05	8.94e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CXCL8—prostate cancer	2.4e-05	8.91e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—JAK2—prostate cancer	2.39e-05	8.9e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CD—prostate cancer	2.39e-05	8.88e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—JAK2—prostate cancer	2.39e-05	8.87e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF1R—prostate cancer	2.38e-05	8.87e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CXCL8—prostate cancer	2.37e-05	8.83e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—JAK2—prostate cancer	2.36e-05	8.78e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LPL—prostate cancer	2.32e-05	8.61e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LPL—prostate cancer	2.31e-05	8.58e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—IL2—prostate cancer	2.3e-05	8.55e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PDGFRB—prostate cancer	2.3e-05	8.53e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CAV1—prostate cancer	2.29e-05	8.53e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—IL2—prostate cancer	2.29e-05	8.52e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PDGFRB—prostate cancer	2.29e-05	8.51e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LPL—prostate cancer	2.29e-05	8.5e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CB—prostate cancer	2.27e-05	8.45e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—IL2—prostate cancer	2.27e-05	8.44e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PDGFRB—prostate cancer	2.27e-05	8.42e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CB—prostate cancer	2.27e-05	8.42e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—NOS3—prostate cancer	2.25e-05	8.38e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CB—prostate cancer	2.24e-05	8.34e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ITGB3—prostate cancer	2.24e-05	8.32e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ITGB3—prostate cancer	2.23e-05	8.29e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ITGB3—prostate cancer	2.21e-05	8.21e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CXCL8—prostate cancer	2.18e-05	8.12e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CXCL8—prostate cancer	2.18e-05	8.09e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ERBB3—prostate cancer	2.17e-05	8.07e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FGFR2—prostate cancer	2.17e-05	8.06e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ERBB3—prostate cancer	2.16e-05	8.04e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FGFR2—prostate cancer	2.16e-05	8.03e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CXCL8—prostate cancer	2.16e-05	8.02e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ERBB3—prostate cancer	2.14e-05	7.96e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FGFR2—prostate cancer	2.14e-05	7.95e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CG—prostate cancer	2.09e-05	7.77e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL2—prostate cancer	2.09e-05	7.76e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CB—prostate cancer	2.08e-05	7.74e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL2—prostate cancer	2.08e-05	7.74e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TERT—prostate cancer	2.08e-05	7.73e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TERT—prostate cancer	2.07e-05	7.71e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTGS2—prostate cancer	2.06e-05	7.67e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL2—prostate cancer	2.06e-05	7.66e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TERT—prostate cancer	2.05e-05	7.63e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HIF1A—prostate cancer	1.99e-05	7.39e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HIF1A—prostate cancer	1.98e-05	7.37e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—INS—prostate cancer	1.98e-05	7.35e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HIF1A—prostate cancer	1.96e-05	7.3e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—LEP—prostate cancer	1.94e-05	7.22e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CREBBP—prostate cancer	1.94e-05	7.2e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—LEP—prostate cancer	1.94e-05	7.2e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CAV1—prostate cancer	1.92e-05	7.15e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CAV1—prostate cancer	1.92e-05	7.13e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—LEP—prostate cancer	1.92e-05	7.13e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KDR—prostate cancer	1.9e-05	7.07e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CAV1—prostate cancer	1.9e-05	7.06e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KDR—prostate cancer	1.9e-05	7.05e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KDR—prostate cancer	1.88e-05	6.98e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ESR1—prostate cancer	1.85e-05	6.89e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ESR1—prostate cancer	1.85e-05	6.87e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CD—prostate cancer	1.84e-05	6.83e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ESR1—prostate cancer	1.83e-05	6.8e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—BAD—prostate cancer	1.81e-05	6.73e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—BAD—prostate cancer	1.8e-05	6.71e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTEN—prostate cancer	1.8e-05	6.69e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—BAD—prostate cancer	1.79e-05	6.64e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APC—prostate cancer	1.75e-05	6.51e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CG—prostate cancer	1.75e-05	6.51e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APC—prostate cancer	1.75e-05	6.49e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CG—prostate cancer	1.75e-05	6.49e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—NOS3—prostate cancer	1.73e-05	6.45e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EGF—prostate cancer	1.73e-05	6.44e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IRS1—prostate cancer	1.73e-05	6.44e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CG—prostate cancer	1.73e-05	6.43e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APC—prostate cancer	1.73e-05	6.43e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EGF—prostate cancer	1.73e-05	6.42e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IRS1—prostate cancer	1.73e-05	6.42e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—EP300—prostate cancer	1.72e-05	6.38e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IRS1—prostate cancer	1.71e-05	6.36e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EGF—prostate cancer	1.71e-05	6.36e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GSK3B—prostate cancer	1.68e-05	6.25e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GSK3B—prostate cancer	1.68e-05	6.23e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GSK3B—prostate cancer	1.66e-05	6.17e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—INS—prostate cancer	1.66e-05	6.17e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—INS—prostate cancer	1.65e-05	6.15e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—INS—prostate cancer	1.64e-05	6.09e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CREBBP—prostate cancer	1.62e-05	6.04e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CREBBP—prostate cancer	1.62e-05	6.02e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IGF1—prostate cancer	1.6e-05	5.96e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CREBBP—prostate cancer	1.6e-05	5.96e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CB—prostate cancer	1.6e-05	5.95e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IGF1—prostate cancer	1.6e-05	5.95e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—EGFR—prostate cancer	1.6e-05	5.94e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—EGFR—prostate cancer	1.59e-05	5.92e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTGS2—prostate cancer	1.59e-05	5.9e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IGF1—prostate cancer	1.58e-05	5.89e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—EGFR—prostate cancer	1.58e-05	5.86e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MAP2K1—prostate cancer	1.55e-05	5.76e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MAP2K1—prostate cancer	1.55e-05	5.75e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CD—prostate cancer	1.54e-05	5.73e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CD—prostate cancer	1.54e-05	5.71e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MAP2K1—prostate cancer	1.53e-05	5.69e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PIK3CA—prostate cancer	1.53e-05	5.67e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SERPINE1—prostate cancer	1.52e-05	5.66e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PIK3CA—prostate cancer	1.52e-05	5.65e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CD—prostate cancer	1.52e-05	5.65e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SERPINE1—prostate cancer	1.52e-05	5.65e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—KRAS—prostate cancer	1.51e-05	5.61e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PIK3CA—prostate cancer	1.51e-05	5.6e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SERPINE1—prostate cancer	1.5e-05	5.59e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—KRAS—prostate cancer	1.5e-05	5.59e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—KRAS—prostate cancer	1.49e-05	5.53e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FGF2—prostate cancer	1.47e-05	5.48e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FGF2—prostate cancer	1.47e-05	5.47e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FGF2—prostate cancer	1.46e-05	5.41e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NOS3—prostate cancer	1.45e-05	5.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NOS3—prostate cancer	1.45e-05	5.39e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NOS3—prostate cancer	1.44e-05	5.34e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—JAK2—prostate cancer	1.41e-05	5.26e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—JAK2—prostate cancer	1.41e-05	5.24e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—JAK2—prostate cancer	1.4e-05	5.19e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PIK3CA—prostate cancer	1.39e-05	5.15e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTEN—prostate cancer	1.38e-05	5.14e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PIK3CA—prostate cancer	1.38e-05	5.13e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MDM2—prostate cancer	1.38e-05	5.13e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MDM2—prostate cancer	1.38e-05	5.11e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PIK3CA—prostate cancer	1.37e-05	5.09e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MDM2—prostate cancer	1.36e-05	5.06e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ERBB2—prostate cancer	1.36e-05	5.06e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ERBB2—prostate cancer	1.36e-05	5.04e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ERBB2—prostate cancer	1.34e-05	4.99e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CB—prostate cancer	1.34e-05	4.99e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CB—prostate cancer	1.34e-05	4.98e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CB—prostate cancer	1.33e-05	4.93e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—EP300—prostate cancer	1.32e-05	4.9e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CXCL8—prostate cancer	1.29e-05	4.8e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CXCL8—prostate cancer	1.29e-05	4.78e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CXCL8—prostate cancer	1.27e-05	4.74e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PIK3CA—prostate cancer	1.27e-05	4.72e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CDKN1B—prostate cancer	1.26e-05	4.68e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CDKN1B—prostate cancer	1.26e-05	4.67e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT1—prostate cancer	1.25e-05	4.63e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CDKN1B—prostate cancer	1.24e-05	4.62e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT1—prostate cancer	1.24e-05	4.62e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CASP3—prostate cancer	1.23e-05	4.59e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL2—prostate cancer	1.23e-05	4.58e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CASP3—prostate cancer	1.23e-05	4.58e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT1—prostate cancer	1.23e-05	4.57e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL2—prostate cancer	1.23e-05	4.57e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6—prostate cancer	1.23e-05	4.56e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6—prostate cancer	1.22e-05	4.55e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CASP3—prostate cancer	1.22e-05	4.53e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL2—prostate cancer	1.22e-05	4.53e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6—prostate cancer	1.21e-05	4.5e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCND1—prostate cancer	1.2e-05	4.47e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCND1—prostate cancer	1.2e-05	4.45e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CTNNB1—prostate cancer	1.19e-05	4.43e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCND1—prostate cancer	1.19e-05	4.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CTNNB1—prostate cancer	1.19e-05	4.41e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CTNNB1—prostate cancer	1.17e-05	4.37e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MMP9—prostate cancer	1.17e-05	4.34e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MMP9—prostate cancer	1.16e-05	4.33e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CDKN1A—prostate cancer	1.16e-05	4.32e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTEN—prostate cancer	1.16e-05	4.31e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CDKN1A—prostate cancer	1.16e-05	4.31e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTEN—prostate cancer	1.16e-05	4.3e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MMP9—prostate cancer	1.15e-05	4.28e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	1.15e-05	4.27e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTEN—prostate cancer	1.15e-05	4.26e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT1—prostate cancer	1.13e-05	4.21e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT1—prostate cancer	1.13e-05	4.19e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT1—prostate cancer	1.12e-05	4.15e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EP300—prostate cancer	1.11e-05	4.11e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EP300—prostate cancer	1.1e-05	4.1e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EP300—prostate cancer	1.09e-05	4.06e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SRC—prostate cancer	1.08e-05	4e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SRC—prostate cancer	1.07e-05	3.99e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SRC—prostate cancer	1.06e-05	3.95e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VEGFA—prostate cancer	1.05e-05	3.9e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VEGFA—prostate cancer	1.04e-05	3.88e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—STAT3—prostate cancer	1.04e-05	3.86e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AKT1—prostate cancer	1.04e-05	3.85e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VEGFA—prostate cancer	1.03e-05	3.85e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—STAT3—prostate cancer	1.03e-05	3.85e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—STAT3—prostate cancer	1.02e-05	3.81e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PIK3CA—prostate cancer	9.76e-06	3.63e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MYC—prostate cancer	9.64e-06	3.58e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TGFB1—prostate cancer	9.62e-06	3.58e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MYC—prostate cancer	9.61e-06	3.57e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TGFB1—prostate cancer	9.59e-06	3.56e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MYC—prostate cancer	9.52e-06	3.54e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TGFB1—prostate cancer	9.49e-06	3.53e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—EGFR—prostate cancer	9.43e-06	3.51e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—EGFR—prostate cancer	9.4e-06	3.5e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—EGFR—prostate cancer	9.31e-06	3.46e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KRAS—prostate cancer	8.91e-06	3.31e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KRAS—prostate cancer	8.88e-06	3.3e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KRAS—prostate cancer	8.79e-06	3.27e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	8.18e-06	3.04e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	8.16e-06	3.03e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	8.08e-06	3e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AKT1—prostate cancer	7.97e-06	2.96e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TP53—prostate cancer	7.92e-06	2.94e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TP53—prostate cancer	7.89e-06	2.93e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TP53—prostate cancer	7.81e-06	2.91e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6—prostate cancer	7.25e-06	2.69e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6—prostate cancer	7.22e-06	2.69e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6—prostate cancer	7.15e-06	2.66e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT1—prostate cancer	6.69e-06	2.49e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT1—prostate cancer	6.66e-06	2.48e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT1—prostate cancer	6.6e-06	2.45e-05	CbGpPWpGaD
